442 related articles for article (PubMed ID: 24647921)
1. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
Psychopharmacology (Berl); 2014 Sep; 231(18):3799-807. PubMed ID: 24647921
[TBL] [Abstract][Full Text] [Related]
2. Effects of varenicline on smoking cue–triggered neural and craving responses.
Franklin T; Wang Z; Suh JJ; Hazan R; Cruz J; Li Y; Goldman M; Detre JA; O'Brien CP; Childress AR
Arch Gen Psychiatry; 2011 May; 68(5):516-26. PubMed ID: 21199958
[TBL] [Abstract][Full Text] [Related]
3. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
[TBL] [Abstract][Full Text] [Related]
4. Varenicline decreases alcohol consumption in heavy-drinking smokers.
Mitchell JM; Teague CH; Kayser AS; Bartlett SE; Fields HL
Psychopharmacology (Berl); 2012 Oct; 223(3):299-306. PubMed ID: 22547331
[TBL] [Abstract][Full Text] [Related]
5. Effects of varenicline on alcohol cue reactivity in heavy drinkers.
Roberts W; Harrison ELR; McKee SA
Psychopharmacology (Berl); 2017 Sep; 234(18):2737-2745. PubMed ID: 28600734
[TBL] [Abstract][Full Text] [Related]
6. Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial.
Wetherill RR; Spilka N; Jagannathan K; Morris P; Romer D; Pond T; Lynch KG; Franklin TR; Kranzler HR
Neuropsychopharmacology; 2021 Jul; 46(8):1414-1420. PubMed ID: 33558678
[TBL] [Abstract][Full Text] [Related]
7. Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers.
Vatsalya V; Gowin JL; Schwandt ML; Momenan R; Coe MA; Cooke ME; Hommer DW; Bartlett S; Heilig M; Ramchandani VA
Int J Neuropsychopharmacol; 2015 Jul; 18(12):. PubMed ID: 26209857
[TBL] [Abstract][Full Text] [Related]
8. Varenicline reduces alcohol self-administration in heavy-drinking smokers.
McKee SA; Harrison EL; O'Malley SS; Krishnan-Sarin S; Shi J; Tetrault JM; Picciotto MR; Petrakis IL; Estevez N; Balchunas E
Biol Psychiatry; 2009 Jul; 66(2):185-90. PubMed ID: 19249750
[TBL] [Abstract][Full Text] [Related]
9. Varenicline effects on craving, cue reactivity, and smoking reward.
Brandon TH; Drobes DJ; Unrod M; Heckman BW; Oliver JA; Roetzheim RC; Karver SB; Small BJ
Psychopharmacology (Berl); 2011 Nov; 218(2):391-403. PubMed ID: 21559801
[TBL] [Abstract][Full Text] [Related]
10. Impact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers.
Gass JC; Wray JM; Hawk LW; Mahoney MC; Tiffany ST
Psychopharmacology (Berl); 2012 Sep; 223(1):107-16. PubMed ID: 22476610
[TBL] [Abstract][Full Text] [Related]
11. A preliminary investigation of varenicline for heavy drinking smokers.
Fucito LM; Toll BA; Wu R; Romano DM; Tek E; O'Malley SS
Psychopharmacology (Berl); 2011 Jun; 215(4):655-63. PubMed ID: 21221531
[TBL] [Abstract][Full Text] [Related]
12. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
Lim AC; Roche DJO; Ray LA
J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
[TBL] [Abstract][Full Text] [Related]
13. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
[TBL] [Abstract][Full Text] [Related]
14. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
Crunelle CL; Miller ML; Booij J; van den Brink W
Eur Neuropsychopharmacol; 2010 Feb; 20(2):69-79. PubMed ID: 19959340
[TBL] [Abstract][Full Text] [Related]
15. The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure.
Lawson SC; Gass JC; Cooper RK; Tonkin SS; Colder CR; Mahoney MC; Tiffany ST; Hawk LW
Psychopharmacology (Berl); 2021 Feb; 238(2):599-609. PubMed ID: 33219852
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
Schacht JP; Randall PK; Latham PK; Voronin KE; Book SW; Myrick H; Anton RF
Neuropsychopharmacology; 2017 Dec; 42(13):2640-2653. PubMed ID: 28409564
[TBL] [Abstract][Full Text] [Related]
17. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
Grodin EN; Burnette EM; Green R; Lim AC; Miotto K; Ray LA
Drug Alcohol Depend; 2021 Aug; 225():108825. PubMed ID: 34175784
[TBL] [Abstract][Full Text] [Related]
18. Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study.
Hartwell KJ; Lematty T; McRae-Clark AL; Gray KM; George MS; Brady KT
Am J Drug Alcohol Abuse; 2013 Mar; 39(2):92-8. PubMed ID: 23421569
[TBL] [Abstract][Full Text] [Related]
19. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.
Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED
Psychopharmacology (Berl); 2014 Oct; 231(19):3843-53. PubMed ID: 24733235
[TBL] [Abstract][Full Text] [Related]
20. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
West R; Baker CL; Cappelleri JC; Bushmakin AG
Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
